Efficacy and tolerability of a single-pill combination of telmisartan/ hydrochlorothiazide 80/25 mg in Chinese and Korean patients with moderate to severe hypertension： a subgroup analysis of a randomized, double-blind, active-controlled trial
Efficacy and tolerability of a single-pill combination of telmisartan/ hydrochlorothiazide 80/25 mg in Chinese and Korean patients with moderate to severe hypertension： a subgroup analysis of a randomized, double-blind, active-controlled trial作者机构：Shanghai Ruijin Hosp Shanghai Inst Hypertens Shanghai 200025 Peoples R China Shanghai Jiao Tong Univ Coll Med Shanghai Peoples Hosp 1 Dept Cardiol Shanghai 200080 Peoples R China Chonnam Natl Univ Hosp Heart Res Ctr Kwangju South Korea Boehringer Ingelheim Int GmbH Ingelheim Germany
出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)
年 卷 期：2013年第126卷第21期
页 面：4072-4077页
核心收录：
学科分类：0710[理学-生物学] 1007[医学-药学(可授医学、理学学位)] 100704[医学-药物分析学] 1002[医学-临床医学] 07[理学] 071009[理学-细胞生物学] 09[农学] 0901[农学-作物学] 090102[农学-作物遗传育种] 10[医学]
基 金：supported by Boehringer Ingelheim International GmbH
主 题：Chinese hydrochlorothiazide hypertension Korean single-pill combination telmisartan
摘 要：Background Hypertension is an important issue in Asia, responsible for up to 66% of cardiovascular disease cases. This randomized controlled trial subgroup analysis compared telmisartan 80 mg （T80）/hydrochlorothiazide 25 mg （H25） single- pill combination with T80 monotherapy, specifically in Chinese and Korean patients.
维普期刊数据库